Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans

Journal of Diabetes

Volumn 8, Issue 5, 2016, Pages 657-666

  Kim, Hong Kyu ^a   Lee, Jung Bok ^a   Kim, Seon Ha ^a   Jo, Min Woo ^a   Kim, Eun Hee ^a   Hwang, Jenie Yoonoo ^a   Bae, Sung Jin ^a   Jung, Chang Hee ^a   Lee, Woo Je ^a   Park, Joong Yeol ^a   Park, Gyung Min ^a   Kim, Young Hak ^a   Choe, Jaewon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

cardiovascular disease; fasting glucose; HbA1c; Koreans; prediabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSGLYCEMIA; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; ICD-10; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; KOREAN (PEOPLE); MALE; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT;

EID: 84983042623     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12343     Document Type: Article

References (46)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339: 229–34.
2. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA. 2002; 287: 2570–81.
3. Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: Insights from mechanistic studies. Lancet. 2008; 371: 1800–9.
4. The DECODE (Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe) study group, European Diabetes Epidemiology Group. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria. Lancet. 1999; 354: 617–21.
5. Heldgaard PE, Olivarius Nde F, Hindsberger C, Henriksen JE. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: Population-based, cross-sectional study of risk factors for cardiovascular disease. Diabet Med. 2004; 21: 363–70.
6. Kanaya AM, Herrington D, Vittinghoff E et al. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease. Ann Intern Med. 2005; 142: 813–20.
7. Liu J, Grundy SM, Wang W et al. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J. 2007; 153: 552–8.
8. Nigam A, Bourassa MG, Fortier A, Guertin MC, Tardif JC. Fasting but not postprandial (postmeal) glycemia predicts the risk of death in subjects with coronary artery disease. Can J Cardiol. 2007; 23: 873–8.
9. Pankow JS, Kwan DK, Duncan BB et al. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: The Atherosclerosis Risk in Communities Study. Diabetes Care. 2007; 30: 325–31.
10. Levitzky YS, Pencina MJ, D'Agostino RB et al. Impact of impaired fasting glucose on cardiovascular disease: The Framingham Heart Study. J Am Coll Cardiol. 2008; 51: 264–70.
11. Lawes CM, Parag V, Bennett DA et al. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care. 2004; 27: 2836–42.
12. Kim HK, Kim CH, Kim EH et al. Impaired fasting glucose and risk of cardiovascular disease in Korean men and women: The Korean Heart Study. Diabetes Care. 2013; 36: 328–35.
13. Yeboah J, Bertoni AG, Herrington DM et al. Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: The Multi-Ethinic Study of Atherosclerosis. J Am Coll Cardiol. 2011; 58: 140–6.
14. Wen CP, Cheng TY, Tsai SP, Hsu HL, Wang SL. Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care. 2005; 28: 2756–61.
15. The DECODE Study Group. Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001; 161: 397–405.
16. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 1999; 22: 920–4.
17. Liao D, Shofer JB, Boyko EJ et al. Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese–Americans with normal fasting glucose. Diabetes Care. 2001; 24: 39–44.
18. Kim HK, Bae SJ, Choe J. Impact of HbA1c criterion on the detection of subjects with increased risk for diabetes among health check-up recipients in Korea. Diabetes Metab J. 2012; 36: 151–6.
19. Gerstein HC. Fasting versus postload glucose levels: Why the controversy? Diabetes Care. 2001; 24: 1855–7.
20. Phillipou G, Phillips PJ. Intraindividual variation of glycohemoglobin: Implications for interpretation and analytical goals. Clin Chem. 1993; 39: 2305–8.
21. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33(Suppl. 1): S62–9.
22. van't Riet E, Rijkelijkhuizen JM, Alssema M et al. HbA1c is an independent predictor of non-fatal cardiovascular disease in a Caucasian population without diabetes: A 10-year follow-up of the Hoorn Study. Eur J Prev Cardiol. 2012; 19: 23–31.
23. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: The European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004; 141: 413–20.
24. Selvin E, Steffes MW, Zhu H et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010; 362: 800–11.
25. Pai JK, Cahill LE, Hu FB, Rexrode KM, Manson JE, Rimm EB. Hemoglobin A1c is associated with increased risk of incident coronary heart disease among apparently healthy, nondiabetic men and women. J Am Heart Assoc. 2013; 2e000077.
26. Ikeda F, Doi Y, Ninomiya T et al. Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: The Hisayama Study. Cardiovasc Diabetol. 2013; 12: 164.
27. Cederberg H, Saukkonen T, Laakso M et al. Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: A 10-year prospective cohort study. Diabetes Care. 2010; 33: 2077–83.
28. Wang H, Shara NM, Lee ET et al. Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: The Strong Heart Study. Diabetes Care. 2011; 34: 1952–8.
29. Kwon S. Payment system reform for health care providers in Korea. Health Policy Plan. 2003; 18: 84–92.
30. Lee K, Lee S. Effects of the DRG-based prospective payment system operated by the voluntarily participating providers on the cesarean section rates in Korea. Health Policy. 2007; 81: 300–8.
31. World Health Organization (WHO) Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363: 157–63.
32. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: The Framingham Heart Study. Stat Med. 1990; 9: 1501–15.
33. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990; 263: 2893–8.
34. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care. 2002; 25: 1129–34.
35. Yates T, Haffner SM, Schulte PJ et al. Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis. Lancet. 2014; 383: 1059–66.
36. Kirk JK, D'Agostino RB, Bell RA et al. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: A meta-analysis. Diabetes Care. 2006; 29: 2130–6.
37. Kirk JK, Passmore LV, Bell RA et al. Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: A meta-analysis. Diabetes Care. 2008; 31: 240–6.
38. Kehl KG, Findeisen HM, Fardo DW, Bruemmer D, Mannino DM, Sanderson WT. Race-ethnicity as an effect modifier of the association between HbAlc and mortality in U.S. adults without diagnosed diabetes. Eur J Endocrinol. 2011; 165: 275–81.
39. Ridker PM, Danielson E, Fonseca FA et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008; 359: 2195–207.
40. Holman RR, Haffner SM, McMurray JJ et al. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010; 362: 1463–76.
41. Makita Z, Vlassara H, Rayfield E et al. Hemoglobin–AGE: A circulating marker of advanced glycosylation. Science. 1992; 258: 651–3.
42. Goh SY, Cooper ME. The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008; 93: 1143–52.
43. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: Evolving knowledge. J Am Coll Cardiol. 2009; 54: 1561–75.
44. Gopalakrishnan P, Ragland MM, Tak T. Gender differences in coronary artery disease: Review of diagnostic challenges and current treatment. Postgrad Med. 2009; 121: 60–8.
45. Pancholy SB, Shantha GP, Patel T, Cheskin LJ. Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: A meta-analysis. JAMA Intern Med. 2014; 174: 1822–30.
46. Bucholz EM, Butala NM, Rathore SS, Dreyer RP, Lansky AJ, Krumholz HM. Sex differences in long-term mortality after myocardial infarction: A systematic review. Circulation. 2014; 130: 757–67.